tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Company (DE:TKDA)
:TKDA
Germany Market

Takeda Pharmaceutical Company (TKDA) Ratios

Compare
3 Followers

Takeda Pharmaceutical Company Ratios

DE:TKDA's free cash flow for Q2 2024 was ¥0.54. For the 2024 fiscal year, DE:TKDA's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
1.11 0.97 1.21 1.53 1.13
Quick Ratio
0.58 0.57 0.81 1.10 0.79
Cash Ratio
0.20 0.21 0.40 0.54 0.29
Solvency Ratio
0.11 0.13 0.11 0.12 0.08
Operating Cash Flow Ratio
0.31 0.39 0.52 0.57 0.31
Short-Term Operating Cash Flow Coverage
1.95 2.88 5.51 45.63 1.14
Net Current Asset Value
¥ -5.28T¥ -5.21T¥ -4.90T¥ -5.02T¥ -5.62T
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.31 0.33 0.36 0.40
Debt-to-Equity Ratio
0.67 0.69 0.76 0.90 1.08
Debt-to-Capital Ratio
0.40 0.41 0.43 0.47 0.52
Long-Term Debt-to-Capital Ratio
0.38 0.39 0.42 0.47 0.49
Financial Leverage Ratio
2.08 2.20 2.32 2.50 2.71
Debt Service Coverage Ratio
1.85 2.21 3.00 3.67 1.31
Interest Coverage Ratio
1.39 2.89 2.77 2.05 0.61
Debt to Market Cap
0.75 1.29 1.60 1.47 2.00
Interest Debt Per Share
3.19K 2.93K 2.89K 3.13K 3.38K
Net Debt to EBITDA
5.01 3.25 2.95 3.73 5.06
Profitability Margins
Gross Profit Margin
66.43%69.11%68.99%68.91%66.89%
EBIT Margin
4.04%12.22%11.91%15.54%2.68%
EBITDA Margin
20.51%29.41%33.15%30.76%26.75%
Operating Profit Margin
5.02%12.18%12.91%15.93%3.05%
Pretax Profit Margin
1.24%9.31%8.48%11.45%-1.85%
Net Profit Margin
3.38%7.87%6.45%11.76%1.34%
Continuous Operations Profit Margin
3.38%8.09%6.88%11.76%1.35%
Net Income Per EBT
272.90%84.52%76.03%102.67%-72.82%
EBT Per EBIT
24.66%76.47%65.66%71.91%-60.51%
Return on Assets (ROA)
0.95%2.27%1.75%2.91%0.35%
Return on Equity (ROE)
1.98%4.99%4.05%7.27%0.94%
Return on Capital Employed (ROCE)
1.67%4.27%4.18%4.57%0.94%
Return on Invested Capital (ROIC)
4.44%3.49%3.11%4.67%-0.65%
Return on Tangible Assets
2.66%6.47%4.65%7.57%0.95%
Earnings Yield
2.22%9.34%8.45%11.91%1.74%
Efficiency Ratios
Receivables Turnover
6.11 5.91 4.93 3.93 4.19
Payables Turnover
4.47 4.05 3.74 4.28 5.15
Inventory Turnover
1.18 1.26 1.30 1.32 1.43
Fixed Asset Turnover
2.14 2.38 2.25 2.20 2.37
Asset Turnover
0.28 0.29 0.27 0.25 0.26
Working Capital Turnover Ratio
52.80 22.13 5.14 5.19 7.90
Cash Conversion Cycle
286.63 260.99 257.84 284.30 270.58
Days of Sales Outstanding
59.72 61.78 74.08 92.76 87.05
Days of Inventory Outstanding
308.49 289.42 281.35 276.74 254.42
Days of Payables Outstanding
81.58 90.20 97.59 85.20 70.88
Operating Cycle
368.21 351.20 355.43 369.51 341.47
Cash Flow Ratios
Operating Cash Flow Per Share
457.89 629.69 718.33 647.20 430.10
Free Cash Flow Per Share
150.61 221.33 599.34 495.81 290.29
CapEx Per Share
307.28 408.36 118.99 151.39 139.81
Free Cash Flow to Operating Cash Flow
0.33 0.35 0.83 0.77 0.67
Dividend Paid and CapEx Coverage Ratio
0.93 1.07 2.39 1.94 1.34
Capital Expenditure Coverage Ratio
1.49 1.54 6.04 4.28 3.08
Operating Cash Flow Coverage Ratio
0.15 0.22 0.26 0.22 0.13
Operating Cash Flow to Sales Ratio
0.17 0.24 0.31 0.32 0.20
Free Cash Flow Yield
7.27%10.12%34.40%24.53%17.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
45.02 10.71 11.84 8.40 57.43
Price-to-Sales (P/S) Ratio
1.52 0.84 0.76 0.99 0.77
Price-to-Book (P/B) Ratio
0.89 0.53 0.48 0.61 0.54
Price-to-Free Cash Flow (P/FCF) Ratio
27.53 9.88 2.91 4.08 5.62
Price-to-Operating Cash Flow Ratio
9.05 3.47 2.43 3.12 3.79
Price-to-Earnings Growth (PEG) Ratio
-0.82 0.28 -0.30 0.01 -0.97
Price-to-Fair Value
0.89 0.53 0.48 0.61 0.54
Enterprise Value Multiple
12.43 6.11 5.26 6.94 7.95
Enterprise Value
EV to EBITDA
8.72 6.11 5.26 6.94 7.95
EV to Sales
1.79 1.80 1.74 2.13 2.13
EV to Free Cash Flow
32.38 21.09 6.64 8.81 15.48
EV to Operating Cash Flow
10.65 7.41 5.54 6.75 10.45
Tangible Book Value Per Share
-1.54K -1.74K -1.63K -1.77K -2.22K
Shareholders’ Equity Per Share
4.65K 4.09K 3.63K 3.31K 3.03K
Tax and Other Ratios
Effective Tax Rate
-1.73 0.15 0.24 -0.03 1.73
Revenue Per Share
2.73K 2.60K 2.28K 2.05K 2.11K
Net Income Per Share
92.09 204.29 147.14 240.72 28.41
Tax Burden
2.73 0.85 0.76 1.03 -0.73
Interest Burden
0.31 0.76 0.71 0.74 -0.69
Research & Development to Revenue
0.17 0.16 0.15 0.14 0.15
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.01 0.01 <0.01
Income Quality
4.97 3.08 4.88 2.69 15.12
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis